XML 64 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation (Tables)
12 Months Ended
Dec. 31, 2022
Basis of preparation  
Schedule of changes to the statement of financial position

​

​

​

​

​

​

​

​

​

​

​

​

​

in EUR k

Dec 31, 2021 (as previously reported)

​

Adjustments

​

Dec 31, 2021 (as restated)

​

Dec 31, 2020 (as previously reported)

​

Adjustments

​

Dec 31, 2020 (as restated)

Property, plant and equipment

8,147

​

1,317

​

9,464

​

16,590

​

-

​

16,590

Non‑current assets

39,217

​

1,317

​

40,534

​

53,084

​

-

​

53,084

​

​

​

​

​

​

​

​

​

​

​

​

Trade receivables and contract assets

24,337

​

(875)

​

23,462

​

29,199

​

(211)

​

28,988

Current assets

51,477

​

(875)

​

50,602

​

97,046

​

(211)

​

96,835

Total Assets

90,694

​

442

​

91,136

​

150,130

​

(211)

​

149,919

​

​

​

​

​

​

​

​

​

​

​

​

Equity and liabilities

​

​

​

​

​

​

​

​

​

​

​

Accumulated deficit and other reserves

(109,295)

​

(245)

​

(109,540)

​

(62,888)

​

(851)

​

(63,739)

Equity

27,503

​

(245)

​

27,258

​

65,777

​

(851)

​

64,926

​

​

​

​

​

​

​

​

​

​

​

​

Lease liabilities

15,588

​

(194)

​

15,394

​

17,677

​

-

​

17,677

Other liabilities

-

​

960

​

960

​

-

​

640

​

640

Non‑current liabilities

23,695

​

766

​

24,461

​

27,235

​

640

​

27,875

​

​

​

​

​

​

​

​

​

​

​

​

Lease liabilities

3,409

​

(79)

​

3,330

​

3,528

​

-

​

3,528

Current liabilities

39,496

​

(79)

​

39,417

​

57,118

​

-

​

57,118

Total Equity and Liabilities

90,694

​

442

​

91,136

​

150,130

​

(211)

​

149,919

​

​

Schedule of reconciliation of the Statement of Comprehensive Income

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the year ended Dec 31,

​

For the year ended Dec 31,

in EUR k

2021 (as previously 
reported)

​

Adjustments

​

2021 (as restated)*

​

2020 (as previously 
reported)

​

Adjustments

​

2020 (as restated)*

Revenue

189,923

​

(1,355)

​

188,568

​

128,381

​

(710)

​

127,671

Cost of sales

161,765

​

(1,317)

​

160,448

​

83,437

​

-

​

83,437

Gross profit

28,158

​

(38)

​

28,120

​

44,944

​

(710)

​

44,234

Research and development expenses

19,297

​

-

​

19,297

​

14,935

​

-

​

14,935

General administrative expenses

46,739

​

-

​

46,739

​

40,160

​

-

​

40,160

Selling expenses

9,860

​

-

​

9,860

​

8,026

​

-

​

8,026

Impairment of financial assets

1,140

​

(313)

​

827

​

3,738

​

(102)

​

3,636

Other operating income

2,936

​

331

​

3,267

​

2,394

​

-

​

2,394

Other operating expenses

86

​

-

​

86

​

182

​

-

​

182

Real estate transfer tax expenses

-

​

-

​

-

​

-

​

-

​

-

Operating loss

(46,028)

​

606

​

(45,422)

​

(19,703)

​

(608)

​

(20,311)

Loss for the period

(46,852)

​

606

​

(46,246)

​

(21,378)

​

(608)

​

(21,986)

Total comprehensive loss

(46,309)

​

606

​

(45,703)

​

(21,426)

​

(608)

​

(22,034)

Loss per share- Basic and diluted (in EUR)

(2.06)

​

0.02

​

(2.04)

​

(1.02)

​

(0.03)

​

(1.05)

​

*As restated consolidated statements of comprehensive income for the years ended December 31, 2021 and 2020 have not been re-presented as a result of discontinued operations. Refer to Note 9 – Discontinued Operations.

​

Schedule of reconciliation of the Statement of Cash Flows [Table Text Block]

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the year ended Dec 31,

​

For the year ended Dec 31,

in EUR k

2021 (as previously reported)

​

Adjustments

    

2021 (Restated)*

​

2020 (as previously reported)

​

Adjustments

    

2020 (Restated)*

Operating activities

  

​

​

​

  

​

  

​

​

​

  

Loss before taxes

(46,876)

​

606

​

(46,270)

​

(21,097)

​

(607)

​

(21,704)

Adjustments to reconcile loss to cash flow from operating activities

​

​

​

​

​

​

​

​

​

​

​

Amortization and depreciation

21,291

​

(1,317)

​

19,974

​

15,128

​

-

​

15,128

Expected credit loss allowances on trade receivable and contract liabilities

1,140

​

(313)

​

827

​

3,738

​

(102)

​

3,636

Other non-cash items

(862)

​

41

​

(821)

​

(915)

​

101

​

(814)

Changes in operating assets and liabilities

​

​

​

​

​

​

​

​

​

​

​

Trade receivables and contract assets

4,191

​

664

​

4,855

​

(16,344)

​

172

​

(16,172)

Other liabilities

1,632

​

320

​

1,952

​

6,245

​

436

​

6,681

Net cash flow used in  operating activities

(21,739)

​

-

​

(21,739)

​

8,462

​

-

​

8,462

​

​

​

​

​

​

​

​

​

​

​

​

Investing activities

​

​

​

​

​

​

​

​

​

​

​

Cash flow used in  investing activities

(5,360)

​

-

​

(5,360)

​

(16,151)

​

-

​

(16,151)

​

​

​

​

​

​

​

​

​

​

​

​

Financing activities

​

​

​

​

​

​

​

​

​

​

​

Net cash flow from/ (used in) financing activities

(3,203)

​

-

​

(3,203)

​

14,842

​

-

​

14,842

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents at the end of the period

17,818

​

-

​

17,818

​

48,156

​

-

​

48,156

​

*As restated consolidated statements of comprehensive income for the years ended December 31, 2021 and 2020 have not been re-presented as a result of discontinued operations. Refer to Note 9 – Discontinued Operations.

​